Consensus document for lipid profile testing and reporting in Spanish clinical laboratories: what parameters should a basic lipid profile include?

Author:

Arrobas Velilla Teresa1,Guijarro Carlos2,Ruiz Raquel Campuzano3,Piñero Manuel Rodríguez4,Valderrama Marcos José Francisco5,Pérez Pérez Antonio6,Botana López Antonio M.7,López Ana Morais8,García Donaire José Antonio9,Obaya Juan Carlos10,Guerra Luis Castilla11,Carratalá Vicente Pallares1213,Cabello Isabel Egocheaga14,Lazo Mercedes Salgueira15,Castellanos Rodrigo María Mar16,Mostaza Prieto José María17,Gómez Doblas Juan José18,Buño Soto Antonio19

Affiliation:

1. Spanish Society of Laboratory Medicine (SEQCML), Laboratory of Clinical Biochemistry , Virgen Macarena University Hospital , Seville , Spain

2. Spanish Society of Arteriosclerosis (SEA), Unit of Internal Medicine , Hospital Alcorcón Foundation University Hospital, Rey Juan Carlos University , Madrid , Spain

3. Spanish Society of Cardiology (SEC), Unit of Cardiology , Alcorcón Foundation University Hospital, Association for Vascular Risk and Cardiac Rehabilitation of the Spanish Society of Cardiology , Madrid , Spain

4. Spanish Society of Angiology and Vascular Surgery (SEACV), Cross-center Cádiz-Jerez Unit of Angiology and Vascular Surgery , Puerta del Mar University Hospital , Cádiz , Spain

5. Spanish Society of Cardiovascular and Endovascular Surgery , Cardiovascular Surgery (SECCE), Regional University Hospital of Malaga , Málaga , Spain

6. Spanish Society of Diabetes (SED) , Endocrinology and Nutrition Department , Hospital de la Santa Creu i Sant Pau , Barcelona , Spain

7. Spanish Society of Endocrinology and Nutrition (SEEN), Section of Endocrinology , Lucus Augusti University Hospital , Lugo , Spain

8. Spanish Society of Gastroenterology, Paediatric Hepatology and Nutrition (SEGHNP), Unit of Paediatric Nutrition and Metabolic Diseases , La Paz University Hospital , Madrid , Spain

9. Spanish Society of Hypertension, Spanish League for the Fight Against Arterial Hypertension (SEH-LELHA), Unit of Arterial Hypertension , Hospital Clínico Universitario San Carlos , Madrid , Spain

10. Spanish Society of Family and Community Family (SEMFyC) , CS La Chopera, Alcobendas , Madrid , Spain

11. Spanish Society of Internal Medicine (SEMI), Unit of Hypertension, Lipids and Vascular Risk , Service of Internal Medicine , Seville , Spain

12. Hospital Virgen Macarena, PCDV Departamento de Medicina , University of Seville , Sevilla , Spain

13. Spanish Society of Primary Care Physicians (SEMERGEN), Unit of Health Surveillance, Unión de Mutuas, Department of Medicine , Universitat Jaume I, Castellón , Castellón , Spain

14. Spanish Society of General and Family Doctors (SEMG), Family and Community Medicine , Centro de Salud Isla de Oza, Servicio Madrileño de Salud , Madrid , Spain

15. Spanish Society of Nephrology (SEN), Unit of Nephrology , Virgen Macarena University Hospital , Seville , Spain

16. Spanish Society of Neurology (SEN), Service of Neurology , Complejo Hospitalario Universitario A Coruña/Instituto de Investigación Biomédica A Coruña , Coruña , Spain

17. Spanish Society of Arteriosclerosis (SEA), Service of Internal Medicine , Hospital La Paz-Carlos III , Madrid , Spain

18. Spanish Society of Cardiology (SEC), Service of Cardiology , Virgen de la Victoria University Hospital , Málaga , Spain

19. Spanish Society of Laboratory Medicine (SEQCML), Service of Clinical Biochemistry , La Paz University Hospital , Madrid , Spain

Abstract

Abstract Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control of lipid metabolism disorders is a key challenge in cardiovascular prevention that is far from being achieved in real clinical practice. There is a great heterogeneity in the reports of lipid metabolism from Spanish clinical laboratories, which may contribute to its poor control. For this reason, a working group of the main scientific societies involved in the care of patients at vascular risk, has prepared this document with a consensus proposal on the determination of the basic lipid profile in cardiovascular prevention, recommendations for its realization and unification of criteria to incorporate the lipid control goals appropriate to the vascular risk of the patients in the laboratory reports.

Publisher

Walter de Gruyter GmbH

Subject

Medical Laboratory Technology,Education,Medicine (miscellaneous)

Reference57 articles.

1. Roth, GA, Abate, D, Abate, KH, Abay, SM, Abbafati, C, Abbasi, N, et al.. GBD 2017 Causes of Death Collaborators Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Lond Engl 2018;392:1736–88. https://doi.org/10.1016/S0140-6736(18)32203-7.

2. INE Defunciones por causas (lista reducida) por sexo y grupos de edad(7947). INE Available from: https://www.ine.es/jaxiT3/Datos.htm?t=7947#!tabs-tabla [accedido 16 febrero 2022].

3. Borén, J, Chapman, MJ, Krauss, RM, Packard, CJ, Bentzon, JF, Binder, CJ, et al.. Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 2020;41:2313–30. https://doi.org/10.1093/eurheartj/ehz962.

4. Royo Bordonada, MÁ, Lobos Bejarano, JM, Millán Núñez-Cortés, J, Villar Álvarez, F, Brotons Cuixart, C, Camafort Babkowski, M, et al.. Dislipidemias: un reto pendiente en prevención cardiovascular. Documento de consenso CEIPC/SEA. Med Clínica 2011;137:30.e1–13, https://doi.org/10.1016/j.medcli.2011.02.008.

5. De Backer, G, Jankowski, P, Kotseva, K, Mirrakhimov, E, Reiner, Ž, Rydén, L, et al.. Management of dyslipidaemia in patients with coronary heart disease: results from the ESC-EORP EUROASPIRE V survey in 27 countries. Atherosclerosis 2019;285:135–46. https://doi.org/10.1016/j.atherosclerosis.2019.03.014.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Quo vadis, LDL cholesterol?;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2023-05-31

2. Quo vadis, colesterol de las LDL?;Advances in Laboratory Medicine / Avances en Medicina de Laboratorio;2023-05-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3